Day: October 25, 2019
NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company) today announced that its Board of Directors has declared a quarterly cash dividend of $14.06 per share on the Company’s 5.625% Series A Cumulative Perpetual Convertible Preferred Stock (the “Convertible Preferred Stock”). The quarterly dividend on the Convertible Preferred Stock is payable on November 15, 2019, to holders of record at the close of business on November 1, 2019. About Cowen Inc.Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients...
Community West Bancshares Earns $2.2 Million, or $0.25 Per Diluted Share, in 3Q19; Results Highlighted by Net Interest Margin Expansion; Declares Quarterly Cash Dividend of $0.055 Per Common Share
Written by Customer Service on . Posted in Public Companies.
GOLETA, Calif., Oct. 25, 2019 (GLOBE NEWSWIRE) — Community West Bancshares (Community West or the Company), (NASDAQ: CWBC), parent company of Community West Bank (Bank), today reported earnings of $2.2 million, or $0.25 per diluted share, for the third quarter of 2019 (3Q19), compared to $1.6 million, or $0.18 per diluted share, in 2Q19, and $2.4 million, or $0.27 per diluted share, in 3Q18.In the first nine months of 2019, net income was $5.2 million, or $0.61 per diluted share, compared to $6.1 million, or $0.69 per diluted share, in the first nine months of 2018.“We delivered solid third quarter results, fueled by growing revenues and an expanding net interest margin,” stated Martin E. Plourd, President and Chief Executive Officer. “Loan growth remains steady, with a 5% increase in the loan portfolio compared to a year ago,...
Verizon 5G Ultra Wideband service available in more cities
Written by Customer Service on . Posted in Public Companies.
What you need to know:Verizon 5G Ultra Wideband service is now live in Dallas, Texas and Omaha, NebraskaVerizon 5G Ultra Wideband mobility service is available in 15 US cities with seven 5G-enabled devicesNEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) — You can now access Verizon’s 5G Ultra Wideband network in parts of Dallas and Omaha, bringing the total number of Verizon 5G Ultra Wideband mobility service cities to 15. With Verizon’s 5G Ultra Wideband network, you can enjoy near real-time experiences with high throughput, ultra-low latency and massive capacity. That means downloading movies in seconds versus minutes and supporting mobile workforce applications.“Customers in Dallas and Omaha become the latest to experience the super-fast download speeds delivered by our 5G Ultra Wideband service,” said Kyle Malady, Verizon’s chief...
Teladoc Health Launches Teladoc Medical Experts for Complex Physical and Mental Health Conditions
Written by Customer Service on . Posted in Public Companies.
PURCHASE, NY, Oct. 25, 2019 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces the U.S. launch of Teladoc Medical Experts, the first-of-its-kind, broad-based virtual center of excellence for individuals dealing with a wide range of complex and/or costly mental and physical medical needs. With this unique service, a state-licensed doctor works directly with individuals, regardless of their geographic location, to get timely answers regarding accurate diagnoses and treatment plans advice, as well as to navigate seamlessly across the virtual and in-person healthcare landscape. Teladoc Medical Experts is currently available for more than 100,000 members across the U.S.“Given that nearly one in three adults with medical conditions also have a mental health condition, it is important to approach...
Watch ElectraMeccanica’s First Exclusive Interview From Strategic Partners’ Manufacturing Facility in China
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Oct. 25, 2019 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles, has conducted its first video interview at their strategic partners’ manufacturing facility in Chongqing, China.The facility is owned and operated by ElectraMeccanica’s strategic manufacturing partner, Zongshen, a wholly-owned subsidiary of Zongshen Industrial Group Co. Ltd. an early investor in ElectraMeccanica and China’s largest manufacturer of motorcycles and motorcycle engines.To view the video interview at the Zongshen facility with ElectraMeccanica’s CEO, Paul Rivera, please click here, or visit: https://investors.electrameccanica.com/media.“This interview provides us with an exciting opportunity to discuss our growing team and...
Hudson Global Schedules Conference Call and Webcast
Written by Customer Service on . Posted in Public Companies.
OLD GREENWICH, Conn., Oct. 25, 2019 (GLOBE NEWSWIRE) — Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company, will issue its third quarter financial results for the period ended September 30, 2019 before the market opens on Friday, November 1, 2019.The company will host a conference call to review its results, market trends, and outlook at 10 a.m. ET the same day. The call will be webcast live on the investor relations section of the company’s website, hudsonrpo.com. The archived call will be available on the investor relations section of the company’s website, hudsonrpo.com.If you wish to join the conference call, please use the dial-in information below:Toll-Fee Dial-In Number: (877) 497-1434International Dial-In Number: (929) 387-3951Conference ID #: 2098893About Hudson RPOHudson Global, Inc. is...
Homology Medicines Presents Preclinical Data From Its Investigational PKU Gene Editing Program, Demonstrating Phenotypic Correction and Molecular Confirmation of Editing Precision
Written by Customer Service on . Posted in Public Companies.
BEDFORD, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the oral presentation of preclinical data related to its nuclease-free, homologous recombination-based, in vivo gene editing program for phenylketonuria (PKU) at the European Society of Gene & Cell Therapy (ESGCT) 27th Annual Congress. Homology also presented preclinical data that showed the effect of full and empty capsids on in vivo efficacy with Homology’s adeno-associated virus vectors derived from human hematopoietic stem cells (AAVHSCs), including its investigational phenylketonuria (PKU) gene therapy candidate HMI-102, and comparisons to an AAV5 PKU gene therapy vector.“The ability of AAVs to induce nuclease-free gene editing through homologous recombination has been established for decades,...
Valley National Bancorp Receives Application Waiver for the Acquisition of Oritani Financial Corp. From the Federal Reserve
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Oct. 25, 2019 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY) (“Valley”) announced today it received notice from the Board of Governors of the Federal Reserve System that it waived the requirement for a bank merger application for the previously announced merger of Oritani Financial Corp. (NASDAQ: ORIT) (“Oritani”) with and into Valley (the “Proposed Transaction”). In conjunction with the previously announced approval from the Office of the Comptroller of the Currency, Valley has obtained the requisite regulatory approvals to complete the Proposed Transaction.The Proposed Transaction remains subject to other customary closing conditions, including approval by the shareholders of both Valley and Oritani. Valley and Oritani will hold their respective shareholder meetings on November 14, 2019 to vote on the Proposed...
Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer
Written by Customer Service on . Posted in Public Companies.
SHANGHAI, China and SAN FRANCISCO, Oct. 25, 2019 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that its partner MacroGenics, Inc. (NASDAQ: MGNX) has dosed the first patient in the Phase 2/3 MAHOGANY clinical trial of margetuximab, an investigational, Fc-optimized monoclonal antibody targeting HER2, in combination with a checkpoint inhibitor, with or without chemotherapy, as a potential first-line treatment for patients with HER2-positive gastric cancer (GC) or gastroesophageal junction (GEJ) cancer. The Phase 2/3 clinical trial is planned to be conducted at clinical sites globally, in collaboration with Zai Lab, the regional partner in Greater China. Zai Lab will lead clinical development in its territory by leveraging its regulatory...
Allegiance Bancshares, Inc. Announces Executive Leadership Transition
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Oct. 25, 2019 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, today announced a plan of succession in which Steven F. Retzloff, age 63, the current President of Allegiance, will be promoted to Chief Executive Officer, effective January 1, 2020, succeeding George Martinez in the role. Mr. Retzloff will continue to serve as the executive Chairman of Allegiance Bank (the “Bank”). Mr. Martinez, age 77, will continue to serve as Chairman of Allegiance’s Board of Directors in 2020. In addition, Mr. Martinez will retire as Chief Executive Officer of the Bank and assume the role of Vice Chairman of the Bank on January 1, 2020.“With the company in a strong financial position and with its outstanding culture and people in place, this is the right time for Allegiance...